MedTrace Logo

Effect of the Erchonia® LunulaLaser™ for the Treatment of Toenail Onychomycosis

NCT06006455 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2025-08-01

Study results available
· View outcomes & findings →

Summary

The purpose of this clinical study is to demonstrate the efficacy of the Erchonia LunulaLaser™, for the treatment of onychomycosis of the toenail.

Conditions

  • Onychomycosis of Toenail

Interventions

DEVICE

Erchonia LunulaLaser

405nm violet and 635nm red laser light therapy.

Sponsors & Collaborators

  • Erchonia Corporation

    lead INDUSTRY

Principal Investigators

  • Robin Stones, MB.ChB · Blemish Clinic

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-15
Primary Completion
2024-07-16
Completion
2024-09-10
FDA Device
Yes

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06006455 on ClinicalTrials.gov